- Home
- OXY vs ALC Comparison
OXY vs ALC Comparison
Compare OXY & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXY
- ALC
- Stock Information
- Founded
- OXY 1920
- ALC 1945
- Country
- OXY United States
- ALC Switzerland
- Employees
- OXY N/A
- ALC N/A
- Industry
- OXY Oil & Gas Production
- ALC Ophthalmic Goods
- Sector
- OXY Energy
- ALC Health Care
- Exchange
- OXY Nasdaq
- ALC Nasdaq
- Market Cap
- OXY 41.3B
- ALC 43.2B
- IPO Year
- OXY N/A
- ALC N/A
- Fundamental
- Price
- OXY $44.61
- ALC $87.71
- Analyst Decision
- OXY Hold
- ALC Buy
- Analyst Count
- OXY 19
- ALC 10
- Target Price
- OXY $51.47
- ALC $105.00
- AVG Volume (30 Days)
- OXY 9.8M
- ALC 1.7M
- Earning Date
- OXY 08-06-2025
- ALC 08-19-2025
- Dividend Yield
- OXY 2.15%
- ALC 0.25%
- EPS Growth
- OXY N/A
- ALC 6.66
- EPS
- OXY 1.71
- ALC 2.25
- Revenue
- OXY $27,150,000,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- OXY N/A
- ALC $6.75
- Revenue Next Year
- OXY $4.46
- ALC $7.60
- P/E Ratio
- OXY $26.07
- ALC $38.77
- Revenue Growth
- OXY 0.10
- ALC 3.80
- 52 Week Low
- OXY $34.79
- ALC $80.48
- 52 Week High
- OXY $58.47
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- OXY 54.03
- ALC 51.56
- Support Level
- OXY $43.46
- ALC $85.47
- Resistance Level
- OXY $45.13
- ALC $87.31
- Average True Range (ATR)
- OXY 1.06
- ALC 1.49
- MACD
- OXY 0.09
- ALC -0.06
- Stochastic Oscillator
- OXY 68.83
- ALC 51.31
About OXY Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,327 thousand barrels of oil equivalent per day in 2024 at a ratio of roughly 52% oil and natural gas liquids and 48% natural gas.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.